MedWatch

Orifarm got Covid-19 discount on Takeda purchases: "The timing was in our favor"

When Orifarm bought products worth DKK 4.6bn from Japanese Takeda in spring 2020, it got a solid coronavirus discount due to turbulent times. "The timing was in our favor," says Orifarm CEO Erik Sandberg.

Photo: Orifarm / PR

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list Hear.com, which handles online sales.

Further reading

Related articles

Latest news

See all jobs